Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|July 13, 2023
Unveiling the complexity of transcription factor networks in hematopoietic stem cells: implications for cell therapy and hematological malignanciesAissa Benyoucef, Jody J Haigh, Marjorie Brand
Leukemia|October 13, 2022
JAK/BCL2 inhibition acts synergistically with LSD1 inhibitors to selectively target ETP-ALLAissa Benyoucef, Katharina Haigh, Andrew Cuddihy, et al.
Plos One|December 5, 2012
Assessment of human multi-potent hematopoietic stem/progenitor cell potential using a single in vitro screening systemJulien Calvo, Aissa BenYoucef, Jan Baijer, et al.
Molecular Therapy. Advances|May 15, 2026
Modulating viscosity improves lentiviral transduction of NK cells: A simple solution to a persistent problemMila Bjelica, Aissa Benyoucef, Hugo Romero, et al.
Frontiers in Immunology|October 16, 2018
Rapamycin as an Adjunctive Therapy for NLRC4 Associated Macrophage Activation SyndromeJulie Barsalou, Annaliesse Blincoe, Isabel Fernandez, et al.
The Journal of Allergy and Clinical Immunology|October 7, 2023
NOX2 deficiency enhances priming and activation of the NLRP3 inflammasomeBlandine Monjarret, Sara Shour, Aissa Benyoucef, et al.
Blood|February 25, 2017
PUMILIO/FOXP1 signaling drives expansion of hematopoietic stem/progenitor and leukemia cellsCécile Naudin, Aurore Hattabi, Fabio Michelet, et al.
Stem Cells (Dayton, Ohio)|April 11, 2015
The SCL/TAL1 Transcription Factor Represses the Stress Protein DDiT4/REDD1 in Human Hematopoietic Stem/Progenitor CellsAissa Benyoucef, Julien Calvo, Laurent Renou, et al.
Nucleic Acids Research|February 23, 2020
Alteration of CTCF-associated chromatin neighborhood inhibits TAL1-driven oncogenic transcription program and leukemogenesisYing Li, Ziwei Liao, Huacheng Luo, et al.
The Journal of Clinical Investigation|March 22, 2016
UTX demethylase activity is required for satellite cell-mediated muscle regenerationHervé Faralli, Chaochen Wang, Kiran Nakka, et al.
Pageof 2